Dear Editor, Sickle cell trait is characterized by a heterozygous inheritance of the sickle hemoglobin gene. Unlike sickle cell disease, sickle cell trait is commonly viewed as a benign process in asymptomatic patients [1]. However, a growing number of case reports and observational studies reveal that complications do occur in these individuals [2]. Both microscopic and gross hematuria are the most common complication [3]. About 50% of these cases have been attributed to renal papillary necrosis [4]. Despite this association, the diagnostic workup for cases of hematuria should always include a urine analysis, urine culture, urine cytology, computed tomography (CT) with and without contrast, and cystoscopy with ureteroscopy if necessary. This report aims to highlight the importance of careful diagnostic workup in patients with sickle cell trait presenting with hematuria. A 49-year-old African–American male with sickle cell trait presented with a history of intermittent, sharp left flank pain, and gross hematuria throughout micturition. Aside from hematuria, all other studies including a noncontrast abdomen/pelvis CT scan were unremarkable. His condition was initially attributed to a kidney stone due to spontaneous resolution. However, these episodes recurred with passage of dark red tissue 3 weeks later. A repeat CT was ordered, this time with contrast, along with cystoscopy. Both studies were again negative despite persistence of his symptoms. Given his long history of sickle cell trait and a negative workup, his hematuria was attributed to papillary necrosis. However, his flank pain progressively worsened with continued passage of necrotic tissue, unrelieved by hydration and urine alkalization. He was referred to the hematology clinic where repeat studies were obtained given the severity and increased frequency of his symptoms. An abdomen/pelvis CT revealed a filling defect in the upper collecting system of the left kidney (Fig. 1), suspicious for malignancy, along with multiple subcentimeter periaortic lymph nodes. A retrograde pyelogram confirmed these findings. Ureteroscopy and biopsy demonstrated a high-grade, non-invasive papillary urothelial carcinoma involving the renal pelvis, extending into the left proximal ureter. A metastatic workup including cystoscopy was unremarkable aside from previously noted lymphadenopathy. Laparoscopic left nephroureterectomy was performed with no further evidence of cancer. Two months later, multiple bladder lesions, biopsy-proven as “drop metastases”, were found on cystoscopy and treated with fulguration. He was treated with intravesical mitomycin C and a 6-week course of Bacille Calmette-Guerin (BCG). Since that time, his adenopathy has been stable and he has had only one recurrence at the bladder dome that was treated with fulguration. Intravesical BCG will be continued for another 6 weeks with frequent monitoring for recurrence. B. S. Gill (*) School of Medicine, The George Washington University, 922 24th Street NW, Apt 421, Washington, DC 20037, USA e-mail: bsgill@gwmail.gwu.edu